Published online before print October 22, 2007, doi: 10.1161/CIRCULATIONAHA.107.729939
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
(Circulation. 2007;116:2110-2118.)
© 2007 American Heart Association, Inc.
Epidemiology |
Physical Activity and Reduced Risk of Cardiovascular Events
Potential Mediating Mechanisms
From the Donald W. Reynolds Center for Cardiovascular Research and the Center for Cardiovascular Disease Prevention (S.M., N.C., J.E.B., P.M.R.), Leducq Center for Molecular and Genetic Epidemiology (S.M., P.M.R.), and Divisions of Preventive Medicine (S.M., N.C., J.E.B., P.M.R., I.-M.L.) and Cardiovascular Medicine (S.M., P.M.R.), Brigham and Women’s Hospital, Harvard Medical School, and the Department of Epidemiology, Harvard School of Public Health (N.C., J.E.B., P.M.R., I.-M.L.), Boston, Mass.
Correspondence to Samia Mora, MD, MHS, Brigham and Women’s Hospital, 900 Commonwealth Ave E, Third Floor, Boston, MA 02215. E-mail smora2{at}partners.org
Received July 24, 2007; accepted September 14, 2007.
Background— Higher levels of physical activity are associated with fewer cardiovascular disease (CVD) events. Although the precise mechanisms underlying this inverse association are unclear, differences in several cardiovascular risk factors may mediate this effect.
Methods and Results— In a prospective study of 27 055 apparently healthy women, we measured baseline levels of hemoglobin A1c, traditional lipids (total, low-density lipoprotein, and high-density lipoprotein cholesterol), novel lipids [lipoprotein(a) and apolipoprotein A1 and B-100], creatinine, homocysteine, and inflammatory/hemostatic biomarkers (high-sensitivity C-reactive protein, fibrinogen, soluble intracellular adhesion molecule-1) and used women’s self-reported physical activity, weight, height, hypertension, and diabetes. Mean follow-up was 10.9±1.6 years, and 979 incident CVD events occurred. The risk of CVD decreased linearly with higher levels of activity (P for linear trend <0.001). Using the reference group of <200 kcal/wk of activity yielded age- and treatment-adjusted relative risk reductions associated with 200 to 599, 600 to 1499, and 
1500 kcal/wk of 27%, 32%, and 41%, respectively. Differences in known risk factors explained a large proportion (59.0%) of the observed inverse association. When sets of risk factors were examined, inflammatory/hemostatic biomarkers made the largest contribution to lower risk (32.6%), followed by blood pressure (27.1%). Novel lipids contributed less to CVD risk reduction compared with traditional lipids (15.5% and 19.1%, respectively). Smaller contributions were attributed to body mass index (10.1%) and hemoglobin A1c/diabetes (8.9%), whereas homocysteine and creatinine had negligible effects (<1%).
Conclusions— The inverse association between physical activity and CVD risk is mediated in substantial part by known risk factors, particularly inflammatory/hemostatic factors and blood pressure.
CLINICAL PERSPECTIVE
Related Article:
-
Issue Highlights
Circulation 2007 116: 2095.[Extract] [Full Text]
This article has been cited by other articles:
 |
|
 |
|
  T. Ohira, J. M. Peacock, H. Iso, L. E. Chambless, W. D. Rosamond, and A. R. Folsom Serum and Dietary Magnesium and Risk of Ischemic Stroke: The Atherosclerosis Risk in Communities Study Am. J. Epidemiol., June 15, 2009; 169(12): 1437 - 1444. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 L. Mascitelli, F. Pezzetta, and M. R. Goldstein Letter to the Editor American Journal of Lifestyle Medicine, March 1, 2009; 3(2): 164 - 164. [PDF]
|
|
|
|
 |
|
 J. Shen and J. M. Ordovas Impact of Genetic and Environmental Factors on hsCRP Concentrations and Response to Therapeutic Agents Clin. Chem., February 1, 2009; 55(2): 256 - 264. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Mora, K. Musunuru, and R. S. Blumenthal The Clinical Utility of High-Sensitivity C-Reactive Protein in Cardiovascular Disease and the Potential Implication of JUPITER on Current Practice Guidelines Clin. Chem., February 1, 2009; 55(2): 219 - 228. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P. M Ridker C-Reactive Protein: Eighty Years from Discovery to Emergence as a Major Risk Marker for Cardiovascular Disease Clin. Chem., February 1, 2009; 55(2): 209 - 215. [Full Text] [PDF]
|
|
|
|
 |
|
 D. T. Smith, L. J. Carr, C. Dorozynski, and C. Gomashe Internet-delivered lifestyle physical activity intervention: limited inflammation and antioxidant capacity efficacy in overweight adults J Appl Physiol, January 1, 2009; 106(1): 49 - 56. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Hamer and A. Steptoe Prospective study of physical fitness, adiposity, and inflammatory markers in healthy middle-aged men and women Am. J. Clinical Nutrition, January 1, 2009; 89(1): 85 - 89. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Hamer, G. J. Molloy, and E. Stamatakis Psychological distress as a risk factor for cardiovascular events: pathophysiological and behavioral mechanisms. J. Am. Coll. Cardiol., December 16, 2008; 52(25): 2156 - 2162. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. S. Bassuk and J. E. Manson Lifestyle and Risk of Cardiovascular Disease and Type 2 Diabetes in Women: A Review of the Epidemiologic Evidence American Journal of Lifestyle Medicine, June 1, 2008; 2(3): 191 - 213. [Abstract] [PDF]
|
|
|
|
 |
|
 S. Mohlenkamp, N. Lehmann, F. Breuckmann, M. Brocker-Preuss, K. Nassenstein, M. Halle, T. Budde, K. Mann, J. Barkhausen, G. Heusch, et al. Running: the risk of coronary events : Prevalence and prognostic relevance of coronary atherosclerosis in marathon runners Eur. Heart J., April 21, 2008; (2008) ehn163v1. [Abstract] [Full Text] [PDF]
|
|